Metabolomic Profiling of Obese Patients with Altered Intestinal Permeability Undergoing a Very Low-Calorie Ketogenic Diet.
Francesco Maria CalabreseGiuseppe CelanoGiuseppe RiezzoBenedetta D'AttomaAntonia IgnazziMartina Di ChitoAnnamaria SilaSara De NucciRoberta RinaldiMichele LinsalataMirco VaccaCarmen Aurora ApaMaria De AngelisGianluigi GiannelliGiovanni De PergolaFrancesco RussoPublished in: Nutrients (2023)
A healthy intestinal permeability facilitates the selective transport of nutrients, metabolites, water, and bacterial products, involving cellular, neural, hormonal, and immune factors. An altered intestinal permeability indicates pathologic phenotypes and is associated with the exacerbation of obesity and related comorbidities. To investigate the impact of altered permeability in obese patients undergoing a calorie-restrictive dietary regimen (VLCKD), we collected urinary and fecal samples from obese patients with both normal and altered permeability (determined based on the lactulose/mannitol ratio) before and after treatment. The analysis of volatile organic compounds (VOCs) aids in understanding the metabolites produced by the intestinal microbiota in this unique ecological niche. Furthermore, we examined clinical and anthropometric variables from the cohort and compared them to significant VOC panels. Consequently, we identified specific markers in the metabolomics data that differentiated between normal and altered profiles before and after the diet. These markers indicated how the variable contribution specifically accounted for interleukins and lipopolysaccharides (LPS). The targeted metabolomics experiment detected no differences in measured short-chain fatty acids (SCFA). In summary, our study evaluated metabolomic markers capable of distinguishing low-grade inflammation conditions, exacerbated in more advanced stages of obesity with altered intestinal permeability.
Keyphrases
- weight loss
- bariatric surgery
- obese patients
- roux en y gastric bypass
- endothelial cells
- low grade
- metabolic syndrome
- gastric bypass
- patients undergoing
- type diabetes
- mass spectrometry
- adipose tissue
- insulin resistance
- fatty acid
- chronic obstructive pulmonary disease
- climate change
- weight gain
- squamous cell carcinoma
- risk assessment
- skeletal muscle
- anti inflammatory
- big data
- high fat diet induced
- locally advanced
- machine learning
- drug delivery
- cancer therapy